Latest Distributions News

Janus Henderson Investors has announced an estimated distribution of 22.0378 cents per unit for its Sustainable Credit Active ETF for the period ending 31 January 2025, with key dates set for early February.

ReNerve Limited has reported a remarkable 260% increase in quarterly sales following its successful IPO, alongside strategic distribution deals in Hong Kong and the Middle East. The company is poised for further growth with upcoming clinical data and product developments.

Lion Energy Limited reports significant progress in its green hydrogen project at Port of Brisbane and confirms major oil and gas prospects in Indonesia, setting the stage for future drilling and commercial development.

Franklin Templeton Australia Limited has announced a final distribution of 0.1513 cents per unit for its Franklin Australian Absolute Return Bond Fund, with key dates set for early February 2025.

BluGlass Limited has unveiled significant advances in gallium nitride (GaN) laser technology at SPIE Photonics West, filing three US provisional patents and demonstrating a powerful integrated laser amplifier. These developments position the company at the forefront of quantum, aerospace, and biotech photonics innovation.

Red Hill Minerals reports a robust December quarter with $2.7 million in royalty revenue, a special dividend payout, and promising drilling results across multiple gold and base metal projects.

AGP Investment Management Limited has announced a $0.009 per unit distribution for the Switzer Dividend Growth Fund for January 2025, fully franked and supported by an active Distribution Reinvestment Plan.

Galan Lithium Limited has announced a substantial 150% increase in its Candelas Mineral Resource to 1.6 Mt LCE, lifting its total Hombre Muerto West resource to 9.5 Mt LCE and securing a spot among the world’s top 10 lithium projects.

CurveBeam AI Limited reported a remarkable 150% increase in device purchase orders in Q2 FY25, driven by strong demand for its HiRise™M platform and a new commercial agreement with Stryker. The company is advancing validation of its Enhanced HiRise™ for robotic surgical systems, despite a regulatory delay for its BMD SaaS module.

CurveBeam AI has reported a record quarter for HiRise™ device purchase orders, driven by a strategic expansion with Stryker in Australia and New Zealand. The company also advanced its FDA regulatory pathway for its BMD module, setting sights on mid-2025 submission.

Microba Life Sciences reports a remarkable 102% revenue increase in Q2 FY25, driven by strong sales of its MetaXplore test in Australia and promising early traction in the UK. The company also advances its therapeutic pipeline with key clinical milestones.

Universal Biosensors is expanding its handheld testing portfolio with the upcoming AQUASCOUT water sensor and growing sales of its FDA-approved Xprecia Prime blood coagulation device, targeting multi-billion-dollar markets.